Recurrent Pleural Effusion Case Highlights Diagnostic Challenge Between TB and Other Causes

A new case report in BMC Geriatrics highlights a difficult diagnostic dilemma at the intersection of respiratory medicine and infectious disease: when recurrent pleural effusion reappears, is the cause tuberculous pleurisy—or something else?

The study, authored by Ji and Yang, presents a patient with repeated accumulation of fluid in the pleural space, a condition that can mimic malignancy, autoimmune disorders, pulmonary embolism, or less common infections. Clinicians initially faced uncertainty because clinical presentation alone often overlaps across etiologies.

In the report, the investigators emphasize the limits of symptom-based inference. Persistent or repeatedly recurring effusions can follow indolent courses, and pleural fluid characteristics may not always deliver decisive answers in real-world settings. This is especially challenging when laboratory tests yield inconclusive results or when the patient’s epidemiologic risk is unclear.

To navigate that uncertainty, the authors describe the interpretive role of pleural sampling and downstream analysis, including assessments intended to distinguish infectious inflammation from other pathological processes. They note that tuberculosis-related pleural disease can produce patterns resembling other chronic conditions, complicating interpretation.

The authors also underscore the practical value of integrating diagnostic tools rather than relying on a single assay. Imaging findings and pleural fluid analysis can guide the level of suspicion, but discordant results may still occur, prolonging diagnostic time and delaying targeted therapy.

A key message in the case is that recurrent pleural effusion demands a broad differential diagnosis. Even when tuberculosis is plausible, other diagnoses must remain active in the clinician’s reasoning until evidence narrows the possibilities.

By documenting the decision-making pathway and the diagnostic uncertainty inherent to pleural disease, the report aims to sharpen clinical vigilance and promote more careful interpretation of pleural findings in recurrent cases.

Overall, the publication serves as a reminder that pleural effusion is not a single disease entity, but a final common pathway—one that can reflect tuberculosis, yet also reflect alternative disorders that require different management strategies.